Author

T. Tibbitts

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:non-human primate· 3 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

C. Berry· 2 shared C. Gutzeit· 2 shared M. Kishko· 2 shared M. Koutsoukos· 2 shared N. G. Anosova· 2 shared V. Lecouturier· 2 shared A. Beauvais· 1 shared A. Cook· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Berry

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 preS dTM vaccine booster candidates increase functional antibody responses and cross-neutralization against SARS-CoV-2 variants of concern in non-human primates

V. Pavot, C. Berry, M. Kishko, N. G. Anosova, D. Huang, T. Tibbitts, A. Raillard, S. Gautheron, C. Gutzeit, M. Koutsoukos, R. M. Chicz, V. Lecouturier

This study evaluates booster vaccine formulations in macaques, showing increased neutralizing antibodies and cross-neutralization against SARS-CoV-2 variants and SARS-CoV-1.

bioRxiv · Sep 20, 2021 · PreprintImmunology

Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

J. R. Francica, B. J. Flynn, K. E. Foulds, A. T. Noe, A. P. Werner, I. N. Morre, M. Gagne, T. S. Johnston, C. Tucker, R. L. Davis, B. Flach, S. O'Connell, S. F. Andrew, E. Lamb, D. R. Flebbe, , McDermott

This study shows that an AS03-adjuvanted SARS-CoV-2 spike protein vaccine induces strong antibody responses and protects nonhuman primates from viral challenge.

bioRxiv · Mar 2, 2021 · PreprintImmunology

Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates

K. V. Kalnin, T. Plitnik, M. Kishko, J. Zhang, D. Zhang, A. Beauvais, N. G. Anosova, T. Tibbitts, J. M. DiNapoli, P.-W. D. Huang, J. Huleatt, D. Vincent, K. Fries, S. Karve, R. Goldman, , D. Casimiro

This study evaluates the immunogenicity of the mRNA vaccine MRT5500 in mice and non-human primates, showing it elicits neutralizing antibodies and TH1-biased responses.

bioRxiv · Oct 14, 2020 · PreprintImmunology